1 Introduction

Laser-based desorption ionization techniques are employed for imaging mass spectrometry (IMS) to provide spatial localization and relative abundance of multiple biomolecules directly from tissue sections [1]. For MALDI, several thousand mass spectra are acquired directly from a tissue sample and the spatial distribution of each signal can be plotted to produce hundreds of ion images in a single experiment. This type of specific molecular imaging does not require antibodies or other target-specific reagents but in some cases these agents can be used to gain new information in IMS studies. Although MALDI IMS has proven to be a very powerful technology, it requires a matrix to effect ablation and shows reduced sensitivity for large proteins (>30 kDa). Targeted multiplex mass spectrometry imaging, using antibodies and having a spatial resolution of approximately 50 μm, has been reported as a complementary method for both MALDI IMS and other imaging technologies [2]. In this report, specific primary antibodies were conjugated to small reporter mass tags (~m/z 500) that were used to localize neuroendocrine markers in human pancreatic islet. However, the intracellular expression of these markers could not be achieved [3]. Indeed, the typical size of human pancreatic islets ranges from 25 to 400 μm and the diameter of a single endocrine cell is approximately 10 μm.

Current commercial MALDI instruments employ a reflection geometry mode where the laser beam is focused by a lens on the front surface of the sample. To achieve a high spatial resolution, suitable for a subcellular imaging, the laser beam must be focused to a 1–2 μm spot, placing strict limitations on the working focal length of the lens. In reflection geometry, the short working distance of a standard objective lens, typically 10–15 mm or less is required to achieve sub-cellular spatial resolution would interfere with the ion optics in the source. In previous studies, transmission geometry was used to pass the laser beam through a transparent substrate to focus on the back side of the analyte layer [411]. The working distance of the focusing lens is limited only by a transparent substrate thickness, with no significant interference of the ion optics, such as plume obstruction and electric field disturbances. We believe transmission geometry laser ablation for IMS represents the most favorable approach to achieve sub-cellular spatial resolution [12].

Islets of Langerhans play a key role in maintaining the appropriate level of glucose in blood; dysfunction or destruction of some specific cells of the islets is one of the many causes of diabetes. Islets are embedded in the exocrine acinar cells of pancreas, and are composed of several different endocrine cells specialized to produce different hormones. Beta cells represent 82 % of the total islet cells and produce insulin, alpha cells (15 %–20 %) produce glucagon, delta cells (3 %–10 %) produce somatostatin, and a few cells (1 %) produce pancreatic polypeptide. In tissue, these cell types are difficult to recognize without special staining or immunoassay techniques. Within the cell, hormones are stored in vesicular structures surrounded by a membrane, termed secretory granules [13, 14]. Some proteins (e.g., chromogranin A [49 kDa] and synaptophysin [34 kDa]), are synthesized in islet cells, and these can be used as specific functional neuroendocrine cell markers. The functional role of synaptophysin (a glycoprotein) is postulated to be involved in the intracellular transport and release of hormones. This glycoprotein was initially found in small-vesicle membranes of neurons and has also been demonstrated in microvesicles that have been shown to be widely distributed among various endocrine cells [15, 16]. Synaptophysin is usually imaged in neuroendocrine cells using immunofluorescence and immunoelectron microscopy. Antibodies against these protein and hormones are commercially available, and immunohistochemical investigation of their expression is routinely done in histopathologic laboratories, especially for the functional diagnosis of islet cell tumors of the pancreas [1719]. However, both immunofluorescence and immunohistochemistry/electron microscopy have limited multiplexing capacity.

In this study, we have used mass tags with laser-based mass spectrometry because of the potential of mass spectrometry to image two tagged antibodies bound to the same tissue section. Mass tags can be released and desorbed by the same laser source in a single experiment where each tag has a different mass that is detected with high sensitivity and specificity [20]. The use of mass tags with mass spectrometry avoids some of the complications of fluorescence measurements such as overlapping of emission spectra, quenching, and tissue autofluorescence. We have investigated the expression of synaptophysin and its co-localization with peptide hormones such as insulin and somatostatin in human pancreatic endocrine cells at the sub-cellular level. The aim of this work is to demonstrate that targeted IMS in transmission geometry can be used to image a single mammalian cell and study the immunoreactivity of different neuroendocrine marker antigens in a multiplex assay format to simultaneously detect more than one antigen in a specific single cell type.

2 Materials and Methods

Antibodies against insulin, somatostatin, and synaptophysin have been well-established and are commercially available from Lab Vision (ThermoFisher Scientific, MI, USA). Immunohistochemical studies are routinely performed in a histopathologic laboratory. Antibodies were used as a model system to develop and optimize targeted IMS experiments. Each antibody, specific for a different antigen, was coupled directly with photocleavable mass tags or indirectly with an enzyme-conjugated streptavidin to form an immune complex (IC). In the ‘direct’ assay, the primary antibody carries the photocleavable mass tag, and on laser irradiation, this tag is desorbed and ionized and is mapped directly in one process. In the more classic ‘indirect’ assay, a secondary antibody that is biotinylated and coupled through streptavidin to alkaline phosphatase. When a dye is applied to the tissue, a red-colored precipitate is formed as a result of the enzyme activity, and this precipitate can be directly desorbed and ionized, measured at m/z 323. Since these indirect antibody assays exist in immunohistochemistry, we wanted to employ one together with the direct mass tag assay to evaluate the compatibility of these two assay approaches. A cocktail of ICs specific for different antigens was applied to tissue in a multiplex assay format to detect in a specific single cell different antigens in the same sample. Figure 1 depicts the work flow of the assay illustrating the direct mass tag approach.

Figure 1
figure 1

Concept of direct targeted IMS by LDI in transmission geometry. Antibodies containing laser cleavable mass tags bound to specific antigens in a tissue section and these tags released and measured by LDI MS. In this workflow, a tissue section is fixed onto a glass slide and treated with one or more mass tag antibody reagents and subsequently introduced into the source of the mass spectrometer for laser desorption image analysis. Acquisition of mass spectra in the scanning mode is used to reconstitute images at a specific molecular weight values, illustrated in this scheme for two mass tags shown in red and green in the final image, corresponding to the localization of specific antigens. The yellow color is the result of overlapping of green and red and shows the co-localization of the two proteins

2.1 Photocleavable Mass Tag Synthesis

The synthesis of the photocleavable mass tags, 2,5-dioxopyrrolidin-1-yl-3-{[3-(6-(isopentylamino)-6-oxohexanoyl)-4-methoxyphenyl)bis(4-methoxyphenyl)]methylthio}propanoate (S532) and 2,5-dioxopyrrolidin-1-yl-3-{[tris(4-methoxyphenyl)]methylthio}propanoate (S333), were carried out using the method described by Shchepinov et al. [21].

2.2 Immunohistochemistry Enzyme Precipitable Substrate or Indirect Approach

Human pancreatic tissues were taken from adult human pancreas specimens undergoing pancreaticoduodenectomy because of carcinoma. Our experiments utilized the non-affected part of pancreas that was normal in histology. We chose antigens known to have dense and weak distribution in endocrine pancreas: anti-insulin (clone INS04) (cat. no. MS-P1ABX), anti-synaptophysin (clone SP11) (cat. no. RM-9111-R7), and anti-somatostatin (cat. no. RB-038-R7), from Lab Vision (Thermo Fisher Scientific).

Frozen sections 8 μm thick, were cut, mounted on glass slides and treated with acetone to immobilize antigens. Nonfat milk at 5 % in PBS was used as a blocking reagent. Sections were incubated with a specific primary antibody. After 30 min of incubation at room temperature with the primary antibody, binding was visualized by light microscope using a biotinylated secondary antibody, alkaline phosphatase-conjugated streptavidin, and fast red as a chromogen. The colorimetric detection of phosphatase activity was visualized by an inverted microscope charge-coupled device (CCD) camera on the mass spectrometer and then specific cell types were identified.

2.3 Immunoassay with Photocleavable Mass Tags

Antibodies were diluted 1:50 in PBS (pH 7.6) and the pH was adjusted to approximately 8.5 by addition of a mix of triethylamine in carbon dioxide. The mass tag N-hydroxysuccinimide (NHS) esters were dissolved in anhydrous dimethylsulfoxide at a concentration of 10 mM. Two different photocleavable mass tags were used: S532 (Mw 732), corresponding to a cleaved mass tag of m/z 532, and S333 (Mw 535), corresponding to a cleaved mass tag of m/z 333. Three μL of mass tag NHS ester (10 mM) was added to the antibody solution (50 μL) at pH ~8.5 and the reaction mixture was incubated for 2 h on ice. Non-reacted mass tags were removed with Micro Bio-Spin Chromatography Columns containing tris buffer (cat. No. 732–6222; Bio-Rad, CA, USA) according to manufacturers’ instructions. After incubation at room temperature for 1 h with mass tag-conjugated primary antibodies, slides were washed three times with PBS for 5 min and rinsed once with distilled water. The slides were then mounted directly into an open frame metal MALDI target plate and introduced into the source of the mass spectrometer. Each photocleavable mass tags were released by laser desorption ionization (LDI) in transmission geometry from specific antibodies and analyzed by mass spectrometry. Both immunohistochemistry (IHC) enzyme precipitable substrate (indirect approach) and immunoassays with photocleavable mass tags (direct approach) were performed on the same tissue section. In the experiments that follow, the specific mass tags and antibodies used for each assay are noted.

2.4 Mass Spectrometry Analysis

A transmission geometry TOF instrumental setup, similar to that reported in [11, 12] was employed for these studies. The modified AB SCIEX 4700 MALDI instrument was equipped with a vacuum compatible inverted optical microscope with the z-axis parallel to the central axis of a flight tube to focus a laser beam in the tissue and to ablate/ionize material into the TOF analyzer. A viewport was installed on the back wall of the sample chamber and an opening made in the original translation stage and sample holder to provide delivery of the laser beam and inverted microscope function. The Olympus UPlan 10× microscope objective lens inside the source allowed focusing the laser to 2 μm diameter spot and was mounted on the z-axis translation stage to position the objective focal plane. All residual optics were located outside of the vacuum chamber. The instrument was equipped with a frequency-tripled Nd:YAG laser with a wavelength 355 nm and a repetition rate of 200 Hz. The target was moved in a 2 μm step raster to generate a mass spectral image data. Biomap ver. 3.7.5.5 was used to create MS images.

3 Results and Discussion

We have employed both the direct and indirect antibody assay approaches in this work to evaluate the effectiveness of mixing these approaches, opening the way for use of either or both where antibody reagents are already available.

3.1 Single Immunolabeling

Figure 2 shows the single immunolabeling of insulin using IMS at sub-cellular spatial resolution. In order to visualize pancreatic cells, the tissue was stained with Cresyl Violet and targeted IMS was performed on the same section. Optical images (Figure 2a and b) show islet cells in the islet of Langerhans (circled in green in the Figure 2a) and IMS image of m/z 323 (Figure 2c). The ion at m/z 323 is arbitrarily shown in red in Figure 2c and mapped to the actual red precipitate from the enzyme coupled antibody complex, revealing the spatial distribution of insulin. The precipitate can be directly desorbed and ionized, measured at m/z 323 and used as a mass tag [22]. In this experiment, insulin-positive cells (beta cell) were differentiated from non-insulin cells based on the assay of cytoplasmic insulin using targeted IMS, correlating well with existing knowledge of pancreatic endocrine cell types [18].

Figure 2
figure 2

Single labeling by IMS of insulin immunoreactive cells and differentiation of specific cells producing insulin. (a) Optical image of pancreatic cells stained with cresyl violet. Islet cells are circled in green. (b) Detailed optical image of insulin containing cells (red dotted outline) and non-insulin containing cells (yellow dotted outline). (c) Targeted IMS of m/z 323 for insulin immunoreactive cells is arbitrarily shown in red color

3.2 Double Immunolabeling

Anti-insulin and anti-synaptophysin antibodies were used to simultaneously detect insulin and synaptophysin, respectively, on the same tissue section. The anti-synaptophysin antibody was conjugated to the mass tag S333. This tagged antibody was applied to tissue section to detect synaptophysin, and binding was detected at m/z 333 (Figure 3a). An alkaline phosphatase precipitable color developer (m/z 323) was used to visualize anti-insulin binding activity as previously described (Figure 3b). Co-localization of these two proteins (insulin and synaptophysin) in the beta cell is shown by the yellow color (red + green) in Figure 3c. Since these experiments were done with high spatial resolution (2 μm), we were able to image the intracellular distribution of these two proteins as shown in Figure 3d.

Figure 3
figure 3

Double labeling by targeted IMS of synaptophysin and insulin in pancreatic cells. (a) Snaptophysin immunoreactive cells (m/z 333). (b) Insulin immunoreactive cells (m/z 323). (c) Co-localization (yellow) of synaptophysin (green) and insulin (red). (d) IMS image of the localization of synaptophysin and insulin with 2 μm spatial resolution with the yellow color the result of overlapping of green and red due to co-localization. (e) Mass spectra of the two reporters groups (m/z 323 for the phosphatase precipitable substrate and m/z 333 for the mass tag S333) used to simultaneously image insulin and synaptophysin

Figure 4 shows the double labeling of somatostatin and synatophysin with mass tag S532 (m/z 532) and with the precipitate (m/z 323), respectively, using targeted IMS at sub-cellular resolution in an islet. This experiment demonstrated that just a few endocrine cells are immunoreactive toward somatostatin. The synaptophysin-positive reaction was observed in somatostatin cells (delta cells) and as well in others islet cells. A single cell showing high synaptophysin expression by targeted IMS is shown in Figure 4b. A specific single cell was then imaged to show somatostatin (red) and synaptophysin (green) demonstrating different known cytoplasmic distributions (Figure 4c) with synaptophysin found in microvesicles and somatostatin in secretory granules. Figures 3 and 4 illustrate that synaptophysin was detected in the insulin positive beta cell and also in the somatostatin positive delta cell.

Figure 4
figure 4

Double labeling by targeted IMS of synaptophysin (m/z 323) and somatostatin (m/z 532) in single cells. (a) Optical image of islet cells. (b) Targeted IMS of an immunoreactive islet cell for synaptophysin. (c) Targeted IMS of a delta cell for synaptophysin (green) and somatostatin (red), showing them located in different cellular structures

4 Conclusion

We report a matrix-free method for targeted imaging in transmission geometry laser desorption ionization mass spectrometry of human pancreatic islet at sub-cellular spatial resolution for insulin, synaptophysin, and the less abundant protein somatostatin in pancreatic islets cells. Insulin, synaptophysin, and somatostatin-14 have MW of 5808, 33800, and 1638 Da, respectively. Targeted IMS allows specific analysis of low abundance species and proteins of both high and low molecular weight in tissue sections. Any antigen, for which a suitable antibody exists, can potentially be studied and multiple antigens can be localized simultaneously. The intracellular co-expression of synaptophysin with two hormone peptides (insulin, somatostatin) has been previously reported, and our results correspond well with data obtained by confocal microscopy, reflection fluorescence microscopy, and electron microscopy. Furthermore, the intracellular expression using targeted IMS in transmission geometry of neuroendocrine markers shows that synaptophysin immunoreactivity appears in somatostatin-positive cells but on different vesicular structure. This result corresponds to previous studies, where synaptophysin was found in microvesicles and somatostatin in secretory granules [13, 14, 2325]. Targeted IMS by laser desorption ionization in transmission geometry introduces the possibility of identifying cell types by visualizing several specific proteins and peptide products in a single sample. Moreover, using IHC enzyme precipitable substrates and targeted IMS with photocleavable mass tags, we were able to select a specific single cell in tissue and study the immunoreactivities of this cell.

The colorimetric detection of enzyme activity facilitates the visualization of specific cell of interest. The coupling of IHC and IMS on the same tissue section is an advantage for studying the immunoreactivity of one specific single cell toward other antigens. This provides a unique opportunity to use enzyme or fluorescent labeled immuno-complexes to select a specific group of cells on tissue by mass spectrometry or/and optical or fluorescent microscopy, respectively, and then study the immunoreactivities of these cells on the same section using mass-tagged antibodies to detect antigens of interest.